New York State Common Retirement Fund
XFOR icon

New York State Common Retirement Fund’s X4 Pharmaceuticals XFOR Stock Holding History

New York State Common Retirement Fund’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,721
Closed -$12.2K – 3356
2025
Q1 		$12.2K Hold
1,721
– – ﹤0.01% 3056
2024
Q4 		$37.9K Hold
1,721
– – ﹤0.01% 2931
2024
Q3 		$34.6K Hold
1,721
– – ﹤0.01% 2961
2024
Q2 		$30K Buy
1,721
+3
+0.2% +$98 ﹤0.01% 3179
2024
Q1 		$71.7K Hold
1,718
– – ﹤0.01% 2863
2023
Q4 		$43.2K Sell
1,718
-14
-0.8% -$340 ﹤0.01% 3032
2023
Q3 		$56.6K Buy
1,732
+45
+3% +$1.96K ﹤0.01% 2983
2023
Q2 		$98.2K Buy
+1,687
New +$86.7K ﹤0.01% 2850
2021
Q3 		– Sell
-4
Closed -$1K – 3541
2021
Q2 		$1K Sell
4
-226
-98% -$56.8K ﹤0.01% 3488
2021
Q1 		$59K Hold
230
– – ﹤0.01% 3183
2020
Q4 		$44K Hold
230
– – ﹤0.01% 3199
2020
Q3 		$47K Sell
230
-267
-54% -$64K ﹤0.01% 3146
2020
Q2 		$139K Buy
497
+357
+255% +$97.7K ﹤0.01% 2809
2020
Q1 		$42K Sell
140
-278
-67% -$78.9K ﹤0.01% 3016
2019
Q4 		$134K Buy
418
+177
+73% +$63.5K ﹤0.01% 2911
2019
Q3 		$92K Hold
241
– – ﹤0.01% 3054
2019
Q2 		$108K Buy
241
+213
+761% +$108K ﹤0.01% 3068
2019
Q1 		$14K Hold
28
– – ﹤0.01% 3141
2018
Q4 		$12K Sell
28
-38
-58% -$14.5K ﹤0.01% 3174
2018
Q3 		$19K Hold
66
– – ﹤0.01% 3134
2018
Q2 		$43K Buy
66
+38
+136% +$124K ﹤0.01% 3149
2018
Q1 		$114K Buy
+28
New +$81.5K ﹤0.01% 2927

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New York State Common Retirement Fund's XFOR Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 1,721 shares — an estimated $12.2K sold.

New York State Common Retirement Fund first reported a position in XFOR in Q1 2018 and held it in 22 quarters. The position peaked at $139K in Q2 2020. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,721 X4 Pharmaceuticals shares in Q2 2025, an estimated $12.2K.
  • New York State Common Retirement Fund first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 22 quarters.
  • New York State Common Retirement Fund's X4 Pharmaceuticals position peaked at $139K in Q2 2020.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.